We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Roles of Tissue Factor in Malignant Gliomas

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00201903
First Posted: September 20, 2005
Last Update Posted: April 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Ontario Cancer Research Network
Information provided by:
Ontario Clinical Oncology Group (OCOG)
September 13, 2005
September 20, 2005
April 6, 2017
January 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00201903 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Roles of Tissue Factor in Malignant Gliomas
The Roles of Tissue Factor in Malignant Gliomas
To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma
To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
  • Venous Thromboembolism
  • Brain Tumors
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
October 2006
Not Provided

Inclusion Criteria:

  • participation in PRODIGE
  • adult patients
  • newly diagnosed, biopsy-confirmed grade III/IV malignant gliomas
  • undergone craniotomy or stereotactic biopsy > 2 days and < 4 weeks before

Exclusion Criteria:

  • have known hereditary thrombophilia
  • are receiving experimental antiangiogenic therapy
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Canada,   United States
 
 
NCT00201903
OCOG-2003-TFsubstudy
Yes
Not Provided
Not Provided
Not Provided
Ontario Clinical Oncology Group (OCOG)
Ontario Cancer Research Network
Study Chair: Agnes Lee, MD Hamilton Health Sciences and McMaster University
Principal Investigator: William Geerts, MD Sunnybrook Health Sciences Centre
Principal Investigator: Mark Levine, MD Ontario Clinical Oncology Group (OCOG)
Principal Investigator: James Perry, MD Toronto Sunnybrook Regional Cancer Centre
Principal Investigator: Janusz Rak Hamilton Health Sciences and McMaster University
Principal Investigator: Jeffrey Weitz, MD Hamilton Health Sciences and McMaster University
Ontario Clinical Oncology Group (OCOG)
May 2007
To Top